Jfs Wealth Advisors, LLC Guardant Health, Inc. Transaction History

Jfs Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$21.58 - $29.5 $410 - $560	19 Added 633.33%	22 $0
Q3 2023 Nov 02, 2023	BUY	$25.8 - $39.97 $77 - $119	3 New	3 $0
Q2 2022 Aug 02, 2022	SELL	$28.82 - $77.35 $461 - $1,237	-16 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$48.25 - $100.49 $386 - $803	8 Added 100.0%	16 $1,000
Q4 2021 Feb 03, 2022	BUY	$88.71 - $120.43 $709 - $963	8 New	8 $1,000
Q1 2021 Apr 28, 2021	SELL	$127.04 - $179.1 $3,557 - $5,014	-28 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$99.96 - $135.93 $2,798 - $3,806	28 New	28 $4,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.